IRES-GFP-AXL-KD Citations (3)

Originally described in: The AXL Receptor is a Sensor of Ligand Spatial Heterogeneity.
Meyer AS, Zweemer AJ, Lauffenburger DA Cell Syst. 2015 Jul 29;1(1):25-36. PubMed Journal

Articles Citing IRES-GFP-AXL-KD

Showing 1 to 3 of 3 entries

Show entries

Search table:

Articles
The FAP alpha -activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway. Ye G, Huang M, Li Y, Ouyang J, Chen M, Wen Q, Li X, Zeng H, Long P, Fan Z, Yin J, Ye W, Zhang D. Acta Pharm Sin B. 2022 Mar;12(3):1288-1304. doi: 10.1016/j.apsb.2021.08.015. Epub 2021 Aug 14. PubMed
Analysis of the Human Kinome and Phosphatome by Mass Cytometry Reveals Overexpression-Induced Effects on Cancer-Related Signaling. Lun XK, Szklarczyk D, Gabor A, Dobberstein N, Zanotelli VRT, Saez-Rodriguez J, von Mering C, Bodenmiller B. Mol Cell. 2019 Jun 6;74(5):1086-1102.e5. doi: 10.1016/j.molcel.2019.04.021. Epub 2019 May 14. PubMed
The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer. Antony J, Tan TZ, Kelly Z, Low J, Choolani M, Recchi C, Gabra H, Thiery JP, Huang RY. Sci Signal. 2016 Oct 4;9(448):ra97. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.